share_log

Maxim Group Initiates Coverage On Lipella Pharmaceuticals With Buy Rating, Announces Price Target of $2

Moomoo 24/7 ·  Apr 9 11:36

Maxim Group analyst Jason McCarthy initiates coverage on Lipella Pharmaceuticals (NASDAQ:LIPO) with a Buy rating and announces Price Target of $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment